THBS1 and Hyperglycemia: TSP1 is produced by cells in response to hypoxia [13], inflammation [14] and hyperglycaemia [15], which are relevant to the altered microenvironment following intraportal infusion of islets [5], as well as systemic or localised inflammation associated with diabetes.